Influence of p53 status on radiation and 5-Flourouracil synergy in pancreatic cancer cells

Anticancer Research

Volumn 22, Issue 2 A, 2002, Pages 825-830

  Mohiuddin, Meraj ^a   Chendil, Damodaran ^a   Dey, Swatee ^a   Alcock, Rachael A ^a   Regine, William ^a   Mohiuddin, Mohammed ^a   Ahmed, Mansoor M ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

5 FU; p53; Pancreatic cancer; Radiation

Indexed keywords

CAPAN 2 PROTEIN; FLUOROURACIL; GENE PRODUCT; MESSENGER RNA; PANC 1 PROTEIN; PROTEIN MIA PACA 2; PROTEIN P21 WAFL CIP1; PROTEIN P53; THYMIDYLATE SYNTHASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER RADIOTHERAPY; CLONOGENIC ASSAY; COLONY FORMING UNIT; DRUG SENSITIVITY; GENE CONTROL; GENE MUTATION; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION RESPONSE; RADIOSENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

ANTIMETABOLITES, ANTINEOPLASTIC; CELL SURVIVAL; COMBINED MODALITY THERAPY; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME INDUCTION; FLUOROURACIL; HUMANS; MUTATION; PANCREATIC NEOPLASMS; RADIATION-SENSITIZING AGENTS; RNA, MESSENGER; THYMIDYLATE SYNTHASE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036249661     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Cancer statistics, 1998
2. Participation of p53 protein in the cellular response to DNA damage
3. p53 mutations increase resistance to ionizing radiation.
4. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles
5. Wild-type p53 is a cell cycle checkpoint determinant following irradiation
6. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxiatelangiectasia
7. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
8. Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer
9. p53 protein expression as prognostic factor in human pancreatic cancer
10. Infrequent expression of p21 is related to altered p53 protein in pancreatic carcinoma
11. Frequent somatic mutations and homozygous deletions of the p 16 (MTS1) gene in pancreatic adenocarcinoma
12. Ionizing radiation-inducible apoptosis in the absence of p53 linked to transcription factor EGR-1
13. Low dose fractionated radiation enhances the radiosensitization effect of paclitaxel in colorectal tumor cells with mutant p53
14. EGR-1 induction is required for maximal radiosensitivity in A375-C6 melanoma cells
15. Nucleotide sequence of a functional cDNA for human thymidylate synthase
16. Isolation of human glucose-6-phosphate dehydrogenase (G6PD) cDNA clones: Primary structure of the protein and unusual 5′non-coding region
17. Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells
18. WAI71, a potential mediator of p53 tumor suppression
19. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines
20. p53 point mutations and thymldylate synthase messenger RNA levels in disseminated colorectal cancer: An analysis of response and survival
21. Effective surgical adjuvant therapy for high-risk rectal carcinoma
22. Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma
23. Thymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells
24. Activity of thymidylate synthetase and its inhibition by 5-fluorouracil in highly enzymeoverproducing cells resistant to 10-propargyl-5,8-dideazafolate
25. Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouracil
26. Apoptosis in cancer therapy: Crossing the eshold
27. Mutant p53 proteins have diverse intracellular abilities to oligomerize and activate transcription
28. Radiosensitization of pancreatic cancer cells by 2,2-difluoro-2′deoxycytidine